1 Introduction Type 2 diabetes mellitus (T2DM) has now reached pandemic proportions, being driven by obesity and an ageing global population, with estimates indicating that around 800 million adults worldwide currently have T2DM [1]. Even with the wealth of available educational and therapeutic options, metabolic control remains suboptimal for many people living with T2DM [2].